Ivy Song

3.0k total citations
52 papers, 2.1k citations indexed

About

Ivy Song is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ivy Song has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 22 papers in Virology and 21 papers in Epidemiology. Recurrent topics in Ivy Song's work include HIV/AIDS drug development and treatment (39 papers), HIV Research and Treatment (22 papers) and Cytomegalovirus and herpesvirus research (11 papers). Ivy Song is often cited by papers focused on HIV/AIDS drug development and treatment (39 papers), HIV Research and Treatment (22 papers) and Cytomegalovirus and herpesvirus research (11 papers). Ivy Song collaborates with scholars based in United States, Japan and United Kingdom. Ivy Song's co-authors include Julie Borland, Stephen C. Piscitelli, Sherene Min, Shuguang Chen, Yu Lou, Amanda Peppercorn, Shuguang Chen, Tamio Fujiwara, Toshihiro Wajima and Parul Patel and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Lancet Infectious Diseases and The American Journal of Gastroenterology.

In The Last Decade

Ivy Song

51 papers receiving 2.1k citations

Peers

Ivy Song

VIROL

EPIDE

PPCH

Julie Borland United States

Anne‐Marie Taburet France

Rolf P. G. van Heeswijk Netherlands

Joseph M. Custodio United States

Sara Gibbons United Kingdom

Thomas N. Kakuda United States

Sherene Min United States

Camlin Tierney United States

Mark S. Shaefer United States

Caroline Solas France

Julie Borland United States

Ivy Song

1.3k ×0.7

759 ×0.7

VIROL

339 ×0.7

EPIDE

309 ×0.8

304 ×0.9

PPCH

Citations per year, relative to Ivy Song Ivy Song (= 1×) peers Julie Borland

Countries citing papers authored by Ivy Song

Since Specialization

Citations

This map shows the geographic impact of Ivy Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivy Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivy Song more than expected).

Fields of papers citing papers by Ivy Song

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivy Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivy Song. The network helps show where Ivy Song may publish in the future.

Co-authorship network of co-authors of Ivy Song

This figure shows the co-authorship network connecting the top 25 collaborators of Ivy Song. A scholar is included among the top collaborators of Ivy Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivy Song. Ivy Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Song, Ivy, et al.. (2024). Population pharmacokinetics and exposure–response relationships of maribavir in transplant recipients with cytomegalovirus infection. Journal of Pharmacokinetics and Pharmacodynamics. 51(6). 887–904. 2 indexed citations

Ing, Steven, Richard D. Finkelman, Ping He, et al.. (2023). A Phase I Randomized Trial of Once‐Daily Versus Twice‐Daily Recombinant Human Parathyroid Hormone (1‐84) for Hypoparathyroidism. JBMR Plus. 7(7). e10758–e10758. 2 indexed citations

Song, Ivy, et al.. (2023). Pharmacokinetics and Safety Evaluation of Maribavir in Healthy Japanese and Matched White Participants: A Phase 1, Open‐Label Study. Clinical Pharmacology in Drug Development. 12(6). 645–654. 4 indexed citations

Michon, Ingrid, et al.. (2023). Physiologically Based Pharmacokinetic Modeling for Maribavir to Inform Dosing in Drug‐Drug Interaction Scenarios with CYP3A4 Inducers and Inhibitors. The Journal of Clinical Pharmacology. 64(5). 590–600. 6 indexed citations

Farrell, Colm, et al.. (2023). Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus. CPT Pharmacometrics & Systems Pharmacology. 12(5). 719–723. 14 indexed citations

Song, Ivy, et al.. (2022). Population Pharmacokinetics and Exposure–Response Relationships of Maribavir in Transplant Recipients with Cytomegalovirus Infections. Transplantation and Cellular Therapy. 28(3). S368–S369. 4 indexed citations

Song, Ivy, Richard D. Finkelman, & Lan Lan. (2020). A Pharmacokinetic Bridging Study to Compare Systemic Exposure to Budesonide between Budesonide Oral Suspension and ENTOCORT EC in Healthy Individuals. Drugs in R&D. 20(4). 359–367. 12 indexed citations

Song, Ivy, et al.. (2016). Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation. European Journal of Clinical Pharmacology. 72(6). 665–670. 23 indexed citations

Ross, Lisa, Ivy Song, Niki Arya, et al.. (2016). No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects. BMC Infectious Diseases. 16(1). 347–347. 5 indexed citations

10.

Anderson, Matt S., Sauzanne Khalilieh, Ka Lai Yee, et al.. (2016). A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir. Clinical Pharmacokinetics. 56(6). 661–669. 25 indexed citations

11.

Song, Ivy, Julie Borland, Shuguang Chen, et al.. (2014). Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir. European Journal of Clinical Pharmacology. 70(10). 1173–1179. 30 indexed citations

12.

Song, Ivy, Stephen Mark, Shuguang Chen, et al.. (2013). Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects. Drug and Alcohol Dependence. 133(2). 781–784. 15 indexed citations

13.

Dooley, Kelly E., Julie Borland, Shuguang Chen, et al.. (2012). Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(1). 21–27. 143 indexed citations

14.

Lunzen, Jan van, Franco Maggiolo, José Ramón Arribas, et al.. (2011). Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial. The Lancet Infectious Diseases. 12(2). 111–118. 226 indexed citations

15.

Song, Ivy, Julie Borland, Shuguang Chen, et al.. (2011). Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next‐generation HIV integrase inhibitor, S/GSK1349572. British Journal of Clinical Pharmacology. 72(1). 103–108. 55 indexed citations

16.

Min, Sherene, Louis Sloan, Edwin DeJesus, et al.. (2011). Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults. AIDS. 25(14). 1737–1745. 171 indexed citations

17.

Song, Ivy, Sherene Min, Julie Borland, et al.. (2010). The Effect of Lopinavir/Ritonavir and Darunavir/Ritonavir on the HIV Integrase Inhibitor S/GSK1349572 in Healthy Participants. The Journal of Clinical Pharmacology. 51(2). 237–242. 52 indexed citations

18.

Song, Ivy, Sherene Min, Julie Borland, et al.. (2010). Lack of Interaction Between the HIV Integrase Inhibitor S/GSK1349572 and Tenofovir in Healthy Subjects. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(3). 365–367. 29 indexed citations

19.

Johnson, Brendan M., Ivy Song, Kimberly K. Adkison, et al.. (2006). Evaluation of the Drug Interaction Potential of Aplaviroc, a Novel Human Immunodeficiency Virus Entry Inhibitor, Using a Modified Cooperstown 5 + 1 Cocktail. The Journal of Clinical Pharmacology. 46(5). 577–587. 20 indexed citations

20.

Yao, Xiaozhou, Maggie S. McIntyre, Daniel G. Lang, et al.. (2005). Propranolol inhibits the human ether-a-go-go-related gene potassium channels. European Journal of Pharmacology. 519(3). 208–211. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact